Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2013

Jan 16, 2013

30339_dirs_2013-01-16_0c4d2056-f304-4a30-b699-d41ccdc2cfa8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2013-01-14

Reporting Person: ANDERSON MICHAEL A (Vice President & Treasurer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-01-14 Common Stock F 274.0000 $55.0500 Disposed 48617.9276 Direct
2013-01-14 Common Stock G 200.0000 $0.0000 Disposed 48417.9276 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 445.0174 Indirect
Common Stock 4179.3559 Indirect

Footnotes

F1: Change in the amount of securities beneficially owned is due to change of form of ownership from indirect to direct due to the distribution of vested deferred stock units credited to the participants account under the terms of the Nonqualified Deferred Comepnsation Plan for Designated Employees. These deferred stock units were distrubted in the form of unrestricted whole shares of stock and are now held directly by the participant.

F2: Change in amount of securities beneficially owned is due to change of form of ownership from indirect to direct due to the distribution of vested deferred stock units credited to the participant's account under the terms of the Nonqualified Deferred Compensation Plan for Designated Employees. 940 of these deferred stock units were distributed in the form of unrestricted whole shares of stock and are now held directly by the participant and .67 shares were distributed to the participant in cash.